Trade Promotion Section - Embassy of Italy /
ITA - Italian Trade Agency
Trade Promotion Section - Embassy of Italy / ITA - Italian Trade Agency is the Governmental agency that supports the business development of our companies abroad and promotes the attraction of foreign investment in Italy. With a motivated and modern organization and a widespread network of overseas offices, ITA provides information, assistance, consulting, promotion and training to Italian small and medium-sized businesses. Using the most modern multi-channel promotion and communication tools, it acts to assert the excellence of Made in Italy in the world. For more details, visit: https://www.ice.it/en/
- Blue Engineering
- ALMA SERUM
- Bioindustry Park / bioPmed
- Piemonte Agency
- Invest in Tuscany
- CYANAGEN
- Olon S.p.A.
BLUE Engineering is an excellence of Italian design and engineering operating 90% of its turnover in foreign markets, emerging economies and Middle Eastern and SE Asian countries in particular. Founded in 1993 to provide complex calculation and simulation services employs around 180 engineers highly specialized in technical design and engineering at all levels in a number of industrial verticals, primarily in transportation.
Its state-of-the-art Manufacturing and IT/AI division, attending BioJapan, has grown a significant expertise in R&D and solutions for advanced digital applications in sectors like health and clinical care, surgery planning and training, automation in production and logistics, intelligent quality controls and communication networks between devices and complex protocols. Strong multidisciplinary know-how and deep specialization in numerical analysis, allows maximizing speed, quality and efficiency throughout the entire development process.
Its state-of-the-art Manufacturing and IT/AI division, attending BioJapan, has grown a significant expertise in R&D and solutions for advanced digital applications in sectors like health and clinical care, surgery planning and training, automation in production and logistics, intelligent quality controls and communication networks between devices and complex protocols. Strong multidisciplinary know-how and deep specialization in numerical analysis, allows maximizing speed, quality and efficiency throughout the entire development process.
ALMA SERUM is a deep-tech biotechnology platform company redefining active compound delivery for the Beauty, Clinical Skincare, and Pharmaceutical industries. Operating on a highly scalable B2B white-label and hardware-leasing model, the company intercepts industrial agricultural sidestreams to extract premium, bio-active complexes at zero raw material cost. Through a proprietary, vertically integrated electrospinning infrastructure, these complex macromolecules are engineered into the "Invisible Shield" (Cleanical Active-Matrix)—a 100% stable, solid-state, waterless delivery matrix that dissolves instantly upon skin contact to trigger endogenous collagen synthesis from within.
Bioindustry park “Silvano Fumero” (Bip.C.a) is a science and technology park, specialized in Life Sciences and Human Health & Medical Care, established in 1998 and located in the North-West of Italy. Bip.C.a promotes and develops Life Sciences research and innovation by hosting and supporting companies, start-ups and research institutions, as well as managing the local regional innovation cluster, BioPmed since 2009.
Bioindustry park community ranges from Biotech to Pharma, Diagnostics, Medical devices/MedTech, up to Digital Health actors. The stage of development also varies from early stage up to clinical stage and scale-ups, including three multinational (corporate) companies.
Bioindustry park leverages innovation proving a full range of services tailored to Health & Medical Care spin-off, start-ups and scale-ups, providing both laboratories and facilities in the campus and dedicated scientific and business support services to foster their go-to-market strategy and attract both public and risk capital.
Bioindustry park also acts to boost collaborations and networking with a full range of healthcare actors: academia, public and private hospitals and healthcare providers, research institutions, industrial partners, corporates, science parks and different kind of investors (from Business Angels to Family Offices, Venture Capital and Private Equity or Crowdfunding platforms) both at local and international level.
Bioindustry park is Network Partner of EIT Health, EIC, CEBR and IASP.
Bioindustry park community ranges from Biotech to Pharma, Diagnostics, Medical devices/MedTech, up to Digital Health actors. The stage of development also varies from early stage up to clinical stage and scale-ups, including three multinational (corporate) companies.
Bioindustry park leverages innovation proving a full range of services tailored to Health & Medical Care spin-off, start-ups and scale-ups, providing both laboratories and facilities in the campus and dedicated scientific and business support services to foster their go-to-market strategy and attract both public and risk capital.
Bioindustry park also acts to boost collaborations and networking with a full range of healthcare actors: academia, public and private hospitals and healthcare providers, research institutions, industrial partners, corporates, science parks and different kind of investors (from Business Angels to Family Offices, Venture Capital and Private Equity or Crowdfunding platforms) both at local and international level.
Bioindustry park is Network Partner of EIT Health, EIC, CEBR and IASP.
Piemonte, in northwestern Italy, is one of Europe's leading life sciences regions, with expertise spanning medical supplies, devices and equipment; medtech solutions; digital health and AI; regenerative medicine; laboratory equipment; diagnostics; pharmaceuticals and dietary supplements; hospital management services.
The region is home to a world-class network of research centres, multinational corporations and innovative SMEs. Recognized as a hub for innovation, education, and technology transfer, Piemonte offers a highly integrated ecosystem capable of meeting a wide range of healthcare and life sciences procurement needs.
Piemonte's participation in BioJapan is organized by Piemonte Agency within the “Health & Wellness” Integrated Supply Chain Project promoted by Regione Piemonte (Regional Government) and co-financed by the European Regional Development Fund (ERDF) 2021–2027, providing a preferential channel to meet a selected group of leading companies from the region and explore business and partnership opportunities.
The region is home to a world-class network of research centres, multinational corporations and innovative SMEs. Recognized as a hub for innovation, education, and technology transfer, Piemonte offers a highly integrated ecosystem capable of meeting a wide range of healthcare and life sciences procurement needs.
Piemonte's participation in BioJapan is organized by Piemonte Agency within the “Health & Wellness” Integrated Supply Chain Project promoted by Regione Piemonte (Regional Government) and co-financed by the European Regional Development Fund (ERDF) 2021–2027, providing a preferential channel to meet a selected group of leading companies from the region and explore business and partnership opportunities.
“Invest in Tuscany” is the regional “one stop shop” promoting Tuscany as a key investment destination. It assists foreign companies in evaluating the opportunities that exist in Tuscany and in the setting-up and the expansion of their operations in the region with: information, introductions and direct assistance through the process. All the services provided are free of charge, confidential and customized according to the companies requirements.
Founded in 2003 in Bologna, Italy, CYANAGEN Srl is a biotechnology company that designs, develops, and manufactures exclusively its own proprietary technologies for Life Sciences (RUO) and in vitro diagnostics (IVD): chemiluminescent substrates, fluorescent markers, magnetic beads, and DNA/RNA extraction kits, for Western blotting, ELISA/CLIA/FIA, protein labeling, cell imaging, flow cytometry, and genomics.
CYANAGEN is the only Italian company, and among few in Europe, doing this fully in-house, with no third-party technology. Strong OEM partnerships with leading international companies have made us one of the world's top manufacturers of chemiluminescent substrates for Western blotting and ELISA/CLIA.
Our patented technologies deliver exceptional quality, sensitivity, and cost-performance. We also offer OEM solutions, bulk reagents, and services such as organic synthesis and bioconjugation.
Sustainability is core to our vision: recycled packaging, microplastic-free beads, and a water-free tablet format for ECL substrates. Cyanagen collaborates with universities and research centers on global R&D projects.
CYANAGEN is the only Italian company, and among few in Europe, doing this fully in-house, with no third-party technology. Strong OEM partnerships with leading international companies have made us one of the world's top manufacturers of chemiluminescent substrates for Western blotting and ELISA/CLIA.
Our patented technologies deliver exceptional quality, sensitivity, and cost-performance. We also offer OEM solutions, bulk reagents, and services such as organic synthesis and bioconjugation.
Sustainability is core to our vision: recycled packaging, microplastic-free beads, and a water-free tablet format for ECL substrates. Cyanagen collaborates with universities and research centers on global R&D projects.
Olon is a global partner in the development and manufacturing of active pharmaceutical ingredients (APIs) for both CDMO and generic markets. By integrating advanced chemical synthesis with biological processes, the company operates to the highest international standards of safety, quality, and environmental responsibility.
With one of the longest track records in the API industry, Olon combines deep scientific expertise with a broad portfolio of advanced technologies to support pharmaceutical companies in bringing their molecules to market efficiently and successfully.
The company’s global network includes 14 manufacturing sites and 14 R&D centers worldwide, supported by 2,800 professionals, among them 350 R&D specialists. This strong international presence enables Olon to deliver innovation, reliability, and technical excellence at every stage of development and production.
Olon’s capabilities span custom chemical synthesis and microbial fermentation, providing flexible, scalable solutions tailored to each project’s specific requirements. Its facilities feature multi-purpose and dedicated production lines designed to handle varying levels of containment, including ultra-high-containment for high-potency and highly toxic compounds.
Through structured expertise in chemical synthesis and microbial biomanufacturing, Olon stands among the leading international producers of APIs and HPAPIs.
With one of the longest track records in the API industry, Olon combines deep scientific expertise with a broad portfolio of advanced technologies to support pharmaceutical companies in bringing their molecules to market efficiently and successfully.
The company’s global network includes 14 manufacturing sites and 14 R&D centers worldwide, supported by 2,800 professionals, among them 350 R&D specialists. This strong international presence enables Olon to deliver innovation, reliability, and technical excellence at every stage of development and production.
Olon’s capabilities span custom chemical synthesis and microbial fermentation, providing flexible, scalable solutions tailored to each project’s specific requirements. Its facilities feature multi-purpose and dedicated production lines designed to handle varying levels of containment, including ultra-high-containment for high-potency and highly toxic compounds.
Through structured expertise in chemical synthesis and microbial biomanufacturing, Olon stands among the leading international producers of APIs and HPAPIs.
